The Bio Report: Addressing a Global Need with RNA Vaccines and Immunotherapies

Aug 2, 2023 | In the News

Click here to view...

Clinical Trials Arena: The tipping point of outsourcing: To build internally or seek external help?

Jul 25, 2023 | In the News

Click here to view...

A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation

Jul 24, 2023 | Publications

Click here to view...

HDT Bio Publishes Peer-Reviewed Study Demonstrating Advantages of repRNA and LION™ Technology

Jul 24, 2023 | Press Releases

LION™-formulated repRNA vaccination exhibited a significant safety profile, along with enhanced efficacy and biodistribution response when compared to lipid nanoparticle (LNP)-formulated repRNA vaccines in mice Study findings, published in the peer-reviewed...

Frontiers in Medicine: sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients

Jun 29, 2023 | In the News

Click here to view...